KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

EverQuote (EVER) Research & Development (2017 - 2025)

EverQuote (EVER) has disclosed Research & Development for 9 consecutive years, with $8.3 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 8.68% to $8.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $31.5 million through Dec 2025, up 6.6% year-over-year, with the annual reading at $31.5 million for FY2025, 6.6% up from the prior year.
  • Research & Development hit $8.3 million in Q4 2025 for EverQuote, up from $7.9 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $9.3 million in Q3 2021 to a low of $5.9 million in Q4 2023.
  • Historically, Research & Development has averaged $7.8 million across 5 years, with a median of $7.9 million in 2022.
  • Biggest five-year swings in Research & Development: surged 32.73% in 2021 and later fell 20.11% in 2023.
  • Year by year, Research & Development stood at $8.8 million in 2021, then dropped by 15.9% to $7.4 million in 2022, then decreased by 20.11% to $5.9 million in 2023, then grew by 28.53% to $7.6 million in 2024, then increased by 8.68% to $8.3 million in 2025.
  • Business Quant data shows Research & Development for EVER at $8.3 million in Q4 2025, $7.9 million in Q3 2025, and $7.8 million in Q2 2025.